These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7225104)

  • 1. A potent mercapto bi-product analogue inhibitor for human carboxypeptidase N.
    Plummer TH; Ryan TJ
    Biochem Biophys Res Commun; 1981 Jan; 98(2):448-54. PubMed ID: 7225104
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterisation of a carboxypeptidase in human serum distinct from carboxypeptidase N.
    Hendriks D; Scharpé S; van Sande M; Lommaert MP
    J Clin Chem Clin Biochem; 1989 May; 27(5):277-85. PubMed ID: 2760564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of potent and specific inhibitors of carboxypeptidases A and B.
    Ondetti MA; Condon ME; Reid J; Sabo EF; Cheung HS; Cushman DW
    Biochemistry; 1979 Apr; 18(8):1427-30. PubMed ID: 427123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of DL-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid on the blood pressure response to vasoactive substances.
    Salgado HC; Carretero OA; Scicli AG; Murray RD
    J Pharmacol Exp Ther; 1986 Apr; 237(1):204-8. PubMed ID: 2420968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregate anaphylaxis and carboxypeptidase N.
    Ryan JW; Berryer P; Hart MA; Ryan US
    Adv Exp Med Biol; 1986; 198 Pt A():435-43. PubMed ID: 3028062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies on human carboxypeptidases B and N.
    McKay TJ; Phelan AW; Plummer TH
    Arch Biochem Biophys; 1979 Oct; 197(2):487-92. PubMed ID: 507824
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and antihypertensive activity of 5-(2-hydroxyphenyl)-1-(3-mercaptopropionyl)-2-pyrrolidinecarboxylic acids.
    Kato E; Yamamoto K; Kawashima Y; Watanabe T; Oya M; Iso T; Iwao J
    Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):4836-46. PubMed ID: 3830417
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interaction of immobilized carboxypeptidase with a natural inhibitor from human blood plasma].
    Trapeznikova SS; Gontar' ID
    Vopr Med Khim; 1977; (6):840-4. PubMed ID: 595489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of MM creatine kinase isoforms in human plasma by carboxypeptidase N.
    Abendschein DR; Serota H; Plummer TH; Amiraian K; Strauss AW; Sobel BE; Jaffe AS
    J Lab Clin Med; 1987 Dec; 110(6):798-806. PubMed ID: 3681119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enkephalin convertase: potent, selective, and irreversible inhibitors.
    Fricker LD; Plummer TH; Snyder SH
    Biochem Biophys Res Commun; 1983 Mar; 111(3):994-1000. PubMed ID: 6404277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa).
    Islam I; Bryant J; May K; Mohan R; Yuan S; Kent L; Morser J; Zhao L; Vergona R; White K; Adler M; Whitlow M; Buckman BO
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1349-54. PubMed ID: 17189688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic inhibitors of carboxypeptidase N.
    Fisher GH; Ryan JW; Chung A; Plumer TH
    Adv Exp Med Biol; 1986; 198 Pt A():405-10. PubMed ID: 3812090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of kininases.
    Erdös EG
    Fed Proc; 1979 Dec; 38(13):2774-7. PubMed ID: 228988
    [No Abstract]   [Full Text] [Related]  

  • 14. Histargin, a new inhibitor of carboxypeptidase B, produced by actinomycetes.
    Umezawa H; Aoyagi T; Ogawa K; Iinuma H; Naganawa H; Hamada M; Takeuchi T
    J Antibiot (Tokyo); 1984 Sep; 37(9):1088-90. PubMed ID: 6548739
    [No Abstract]   [Full Text] [Related]  

  • 15. A simple spectrophotometric assay of carboxypeptidase N (kininase I) in human serum.
    Schweisfurth H; Reinhart E; Heinrich J; Brugger E
    J Clin Chem Clin Biochem; 1983 Oct; 21(10):605-9. PubMed ID: 6644248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of bradykinin generating and degrading systems in the vascular permeability response induced with kaolin in rats.
    Kumakura S; Kamo I; Tsurufuji S
    Adv Exp Med Biol; 1989; 247B():541-6. PubMed ID: 2610091
    [No Abstract]   [Full Text] [Related]  

  • 17. Contributions of various rat plasma peptidases to kinin hydrolysis.
    Ishida H; Scicli AG; Carretero OA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):817-20. PubMed ID: 2557417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Potentiative effects of angiotensin converting enzyme inhibitors on carrageenan-induced edema in rats].
    Suda H; Yamauchi H; Iso T
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):517-23. PubMed ID: 6298082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of potent, orally active, inhibitors of carboxypeptidase U (TAFIa).
    Polla MO; Tottie L; Nordén C; Linschoten M; Müsil D; Trumpp-Kallmeyer S; Aukrust IR; Ringom R; Holm KH; Neset SM; Sandberg M; Thurmond J; Yu P; Hategan G; Anderson H
    Bioorg Med Chem; 2004 Mar; 12(5):1151-75. PubMed ID: 14980627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical thiol surrogates and protective groups for arylthiols for Suzuki-Miyaura conditions.
    Itoh T; Mase T
    J Org Chem; 2006 Mar; 71(5):2203-6. PubMed ID: 16497021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.